June S&P 500 E-Mini futures (ESM24) are trending down -0.11% this morning as market participants awaited minutes of the Federal Reserve’s latest policy meeting as well as an earnings report from artificial...
REDWOOD CITY, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing...
Company to Host Analyst and Investor Conference Call on Wednesday, May 4 at 4:30 p.m. ET...
REDWOOD CITY, Calif., May 04, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing...
REDWOOD CITY, Calif., May 01, 2022 (GLOBE NEWSWIRE) -- Rezolute, Inc. (Nasdaq: RZLT), a clinical-stage biopharmaceutical company dedicated to developing...
Results Presented Today at the Pediatric Endocrine Society’s 2022 Annual Meeting...
Rezolute joins group aimed at helping advance timely access to life-saving therapies for those impacted by rare diseases...
The RIZE study demonstrated highly significant improvements in hypoglycemia and good safety and tolerability Results to be presented in an oral...
Phase 2 proof-of-concept study anticipated in 2H 2022...
Topline results from RZ358 Phase 2b and RZ402 Phase 1b studies expected before the end of Q1 2022...